Skip to main content

No biotech startup can walk the path to success all alone and unprepared, especially not without the three pillars of Data, Strategy and Team, as KPMG and BaseLaunch write in their joint white paper. These pillars have to be thoroughly sound from a scientific, business and commercial point of view in order to operate within the right network and attract venture funds.

It is both an art and a must to fulfill such criteria and pick the correct ingredients for the successful launch of a biotech startup. Billions are invested in getting biotech startups off the ground annually. When it comes to biotech venture capital investments in Europe alone, Switzerland is in the 3rd place as of 2021, and Basel-based companies are the leaders within Switzerland.

Read the full white paper below to learn what is required for a biotech startup to successfully raise their first venture capital round:

Read white paper

Share this article

View all news

Sign up to receive our newsletter in your inbox.